Literature DB >> 6244959

Parathyroid function and serum calcitonin in children receiving anticonvulsant drugs.

K Kruse, H Bartels, R Ziegler, E Dreller, U Kracht.   

Abstract

Serum calcitonin (CT) levels and other aspects of calcium metabolism were investigated in 40 epileptic children receiving long-term treatment with phenytoin and/or other anticonvulsant drugs, and in 38 age-matched controls. In the patients CT levels were significantly lower. Immunoreactive parathyroid hormone (iPTH) was significantly elevated exceeding the upper limit of controls in 11 patients. We also observed a highly significant correlation between iPTH and urinary cyclic AMP (cAMP) excretion but a lack of such a correlation with the renal handling of phosphate; this indicates to us a dissociation between cAMP production and phosphaturia. A significant correlation between iPTH levels and urinary hydroxyproline excretion points to a normal action of PTH on bone in the patients. The low CT levels are not due to hypocalcemia and may be directly attributed to the effects of anticonvulsant drugs. As the primary effect of CT is a direct inhibition of PTH induced calcium loss from bone, the drug-related low CT levels in association with secondary hyperparathyroidism possibly is an additional factor in anticonvulsant bone disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244959     DOI: 10.1007/bf00441584

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  The action and control of the calcium-regulating hormones.

Authors:  I MacIntyre
Journal:  J Endocrinol Invest       Date:  1978-07       Impact factor: 4.256

2.  Plasma calcitonin in normal man. Differences between men and women.

Authors:  H Heath; G W Sizemore
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

3.  Parathyroid hormone and calcitonin levels in vitamin D deficient rickets.

Authors:  G Zamboni; M Cecchettin; A Albertini; A Andreoli; G Zoppi
Journal:  Eur J Pediatr       Date:  1979-02-08       Impact factor: 3.183

4.  Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal.

Authors:  M Drezner; F A Neelon; H E Lebovitz
Journal:  N Engl J Med       Date:  1973-11-15       Impact factor: 91.245

Review 5.  Bone complications of anticonvulsants.

Authors:  T J Hahn
Journal:  Drugs       Date:  1976       Impact factor: 9.546

6.  Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs.

Authors:  T C Stamp; J M Round; D J Rowe; J G Haddad
Journal:  Br Med J       Date:  1972-10-07

7.  Secretion of calcitonin in hypocalcemic states in man.

Authors:  L J Deftos; D Powell; J G Parthemore; J T Potts
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

8.  Serum calcitonin and blood mineral interrelationships in normal children aged six to twelve years.

Authors:  R Shainkin-Kerstenbaum; B Funkenstein; A Conforti; S Shani; G M Berlyne
Journal:  Pediatr Res       Date:  1977-02       Impact factor: 3.756

9.  Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.

Authors:  W Jubiz; M R Haussler; T A McCain; K G Tolman
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

10.  Relative deficiency of plasma-calcitonin in normal women.

Authors:  C J Hillyard; J C Stevenson; I MacIntyre
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

View more
  3 in total

1.  On the pathogenesis of anticonvulsant-drug-induced alterations of calcium metabolism.

Authors:  K Kruse
Journal:  Eur J Pediatr       Date:  1982-05       Impact factor: 3.183

Review 2.  Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.

Authors:  Sandra J Petty; Helen Wilding; John D Wark
Journal:  Curr Osteoporos Rep       Date:  2016-04       Impact factor: 5.096

3.  Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsant medication.

Authors:  S Nishiyama; T Kuwahara; I Matsuda
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.